Relationship of Monocyte Chemoattractant Protein-1 (MCP-1) with Some Biochemical Parameters in CKD-5 Stage Patients

Saif Bashar Mohammed; Hameed Hussein Ali; Amer Jihad Hussein

doi:10.47419/bjbabs.v7i1.420

Authors

Saif Bashar Mohammed Department of Chemistry, College of Science, University of Anbar, Ramadi, Iraq https://orcid.org/0009-0005-8397-455X
Hameed Hussein Ali Department of Chemistry, College of Science, University of Anbar, Ramadi, Iraq https://orcid.org/0000-0002-9735-1530
Amer Jihad Hussein Iraqi Ministry of Health, Al-Anbar Health Department, Al-Ramadi Teaching Hospital, Ramadi, Anbar, Iraq

DOI:

https://doi.org/10.47419/bjbabs.v7i1.420

Keywords:

monocyte chemoattractant protein-1, end-stage renal disease (ERSD), biochemical markers, acute inflammation, chemokines

Abstract

Background: Monocyte chemoattractant protein-1 (MCP-1) is a pro-inflammatory chemokine increasingly recognized as a biomarker in chronic kidney disease (CKD). Its novelty lies in linking inflammation with renal dysfunction and mineral metabolism disturbances. However, its clinical utility in advanced CKD is not fully established.

Objective: This study evaluated the association of serum MCP-1 with renal, metabolic, and nutritional parameters in end-stage renal disease (ESRD, CKD stage 5) patients undergoing hemodialysis, and assessed its diagnostic performance.

Methods: A case–control study included 58 ESRD patients undergoing maintenance hemodialysis and 30 matched healthy controls. Patients with acute infection, autoimmune disease, malignancy, and liver diseases were excluded. Blood samples were collected before dialysis to measure serum MCP-1, renal function markers, bone-mineral parameters, and nutritional indices. Statistical analyses included independent t-test, Pearson’s correlation, and receiver operator characterization (ROC) curve analysis.

Results: MCP-1 levels were significantly elevated in ESRD, compared to controls (1090.69 ± 465.04 pg/mL vs. 195.33 ± 95.19 pg/mL, P < 0.0001). MCP-1 correlated positively with creatinine, urea, uric acid, phosphorus, and parathyroid hormone, and negatively with estimated glomerular filtration rate, calcium, vitamin D3, albumin, total protein, hemoglobin, and hematocrit
(P < 0.01). ROC analysis revealed excellent diagnostic accuracy (area under curve: 0.99), with sensitivity = 94.8%, specificity = 96.7%, and an optimal cut-off of 382.5 pg/mL.

Conclusion: MCP-1 is markedly elevated in ESRD and strongly associated with renal dysfunction, mineral imbalance, and inflammation. Its high diagnostic accuracy supports its role as a candidate biomarker in advanced CKD, although larger prospective studies are needed to confirm prognostic value and therapeutic implications.